|
Fusion gene ID: 42346 |
FusionGeneSummary for YLPM1_KHDRBS2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: YLPM1_KHDRBS2 | Fusion gene ID: 42346 | Hgene | Tgene | Gene symbol | YLPM1 | KHDRBS2 | Gene ID | 56252 | 202559 |
Gene name | YLP motif containing 1 | KH RNA binding domain containing, signal transduction associated 2 | |
Synonyms | C14orf170|PPP1R169|ZAP113|ZAP3 | SLM-1|SLM1 | |
Cytomap | 14q24.3 | 6q11.1 | |
Type of gene | protein-coding | protein-coding | |
Description | YLP motif-containing protein 1nuclear protein ZAP3protein phosphatase 1, regulatory subunit 169 | KH domain-containing, RNA-binding, signal transduction-associated protein 2KH domain containing, RNA binding, signal transduction associated 2Sam68-like mammalian protein 1 | |
Modification date | 20180519 | 20180522 | |
UniProtAcc | P49750 | Q5VWX1 | |
Ensembl transtripts involved in fusion gene | ENST00000238571, ENST00000325680, ENST00000552421, ENST00000546901, | ENST00000281156, | |
Fusion gene scores | * DoF score | 5 X 8 X 2=80 | 6 X 6 X 6=216 |
# samples | 9 | 6 | |
** MAII score | log2(9/80*10)=0.169925001442312 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(6/216*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: YLPM1 [Title/Abstract] AND KHDRBS2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SARC | TCGA-SI-A71O-01A | YLPM1 | chr14 | 75291010 | + | KHDRBS2 | chr6 | 62442669 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000238571 | ENST00000281156 | YLPM1 | chr14 | 75291010 | + | KHDRBS2 | chr6 | 62442669 | - |
Frame-shift | ENST00000325680 | ENST00000281156 | YLPM1 | chr14 | 75291010 | + | KHDRBS2 | chr6 | 62442669 | - |
Frame-shift | ENST00000552421 | ENST00000281156 | YLPM1 | chr14 | 75291010 | + | KHDRBS2 | chr6 | 62442669 | - |
3UTR-3CDS | ENST00000546901 | ENST00000281156 | YLPM1 | chr14 | 75291010 | + | KHDRBS2 | chr6 | 62442669 | - |
Top |
FusionProtFeatures for YLPM1_KHDRBS2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
YLPM1 | KHDRBS2 |
Plays a role in the reduction of telomerase activityduring differentiation of embryonic stem cells by binding to thecore promoter of TERT and controlling its down-regulation.{ECO:0000250}. | RNA-binding protein that plays a role in the regulationof alternative splicing and influences mRNA splice site selectionand exon inclusion. Binds both poly(A) and poly(U) homopolymers.Phosphorylation by PTK6 inhibits its RNA-binding ability (Bysimilarity). Induces an increased concentration-dependentincorporation of exon in CD44 pre-mRNA by direct binding topurine-rich exonic enhancer. Can regulate alternative splicing ofNRXN1 in the laminin G-like domain 6 containing the evolutionaryconserved neurexin alternative spliced segment 4 (AS4) involved inneurexin selective targeting to postsynaptic partners. Regulatescell-type specific alternative splicing of NRXN1 at AS4 and actssynergystically with SAM68 in exon skipping. In contrast actsantagonistically with SAM68 in NRXN3 exon skipping at AS4. Itsphosphorylation by FYN inhibits its ability to regulate splicesite selection. May function as an adapter protein for Src kinasesduring mitosis. {ECO:0000250|UniProtKB:Q920F3,ECO:0000250|UniProtKB:Q9WU01}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for YLPM1_KHDRBS2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for YLPM1_KHDRBS2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
YLPM1 | PRMT1, CHGB, USP7, USP45, WDR48, MLH1, SRGAP2, RB1CC1, CACNA1A, PPP1CA, ITSN2, SIRT7, CUL3, SPDL1, SPG21, RINT1, PPP1CC, DAB2, HDAC11, GRB2, NONO, PRPF40A, APBB1, WWOX, LGR4, DROSHA, OBSL1, BMI1, PPP1R3A, SMARCC1, SMARCC2, DDX17, B9D2, HNRNPA1, PPP1CB, MATR3, CDC5L, MAGEE1, P4HA3, NAGK, NCK2, FOXA1, HEY1 | KHDRBS2 | EWSR1, RBMX, HNRNPK, KHDRBS3, RPAP2, DDX17, DDX5, HNRNPA1, HNRNPA2B1, HNRNPH1, HNRNPR, SYNCRIP, HNRNPC, IGF2BP1, PRMT1, ILF2, KHDRBS1, HNRNPDL, EHBP1, ARID2, TAF3, DSG1, HNRNPA0, IGF2BP3, HNRNPL, HNRNPUL2, RBM39, ILF3, HNRNPH3, PRMT5, RPS3, FGA, YBX1, FGG, HNRNPD, MRPS27, TARDBP, NUSAP1, SAFB, WDR77, MOV10, HRNR, FGB, DEK, FBXW11, LRRC15, HSP90AB1, LYN, CIRBP, DOCK2, HBZ, PTK6, RBM3, SDCBP, SPG7, SULT1A3, TYK2, MTA1, CHTOP, PRPF31, NPDC1, NCOA5, AEN, NABP1, PRR3, YTHDC1, CATSPER1, ZFC3H1, KHDRBS2, LINC01018, TYMSOS, ATXN2, DDX43, TMEM14B, BTRC, ATG7, WDR45B, YRDC, CRBN, PLCG1, PTER, ACOX1, CAPG, RFWD2, CUL1, SUPT5H, KLHL42, USP7, CTC1, SUZ12, ACAD11, NAGK, FOXA3, ACAA1, MAPK3, AURKA, MVK |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for YLPM1_KHDRBS2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for YLPM1_KHDRBS2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | KHDRBS2 | C0025202 | melanoma | 1 | CTD_human |